Literature DB >> 20171754

Global healthcare expenditure on diabetes for 2010 and 2030.

Ping Zhang1, Xinzhi Zhang, Jonathan Brown, Dorte Vistisen, Richard Sicree, Jonathan Shaw, Gregory Nichols.   

Abstract

AIMS: To estimate the global health expenditure on diabetes among people aged 20-79 years for the years 2010 and 2030.
METHODS: Country-by-country expenditures for 193 countries, expressed in United States Dollars (USD) and in International Dollars (ID), were estimated based on the country's age-sex specific diabetes prevalence and population estimates, per capita health expenditures, and health expenditure ratios per person with and without diabetes. Diabetes prevalence was estimated from studies in 91 countries. Population estimates and health expenditures were from the United Nations and the World Health Organization. The health expenditure ratios were estimated based on utilization and cost data of a large health plan in the U.S. Diabetes expenditures for the year 2030 were projected by considering future changes in demographics and urbanization.
RESULTS: The global health expenditure on diabetes is expected to total at least USD 376 billion or ID 418 billion in 2010 and USD 490 billion or ID 561 billion in 2030. Globally, 12% of the health expenditures and USD 1330 (ID 1478) per person are anticipated to be spent on diabetes in 2010. The expenditure varies by region, age group, gender, and country's income level.
CONCLUSIONS: Diabetes imposes an increasing economic burden on national health care systems worldwide. More prevention efforts are needed to reduce this burden. Meanwhile, the very low expenditures per capita in poor countries indicate that more resources are required to provide basic diabetes care in such settings.

Entities:  

Mesh:

Year:  2010        PMID: 20171754     DOI: 10.1016/j.diabres.2010.01.026

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  313 in total

1.  Leisure-time physical activity and risk of type 2 diabetes: a meta-analysis of prospective cohort studies.

Authors:  Pengcheng Huai; Huiju Han; Kathleen Heather Reilly; Xiaolei Guo; Jiyu Zhang; Aiqiang Xu
Journal:  Endocrine       Date:  2015-10-19       Impact factor: 3.633

2.  Healthy Living Partnerships to Prevent Diabetes: recruitment and baseline characteristics.

Authors:  Caroline S Blackwell; Kara A Foster; Scott Isom; Jeffrey A Katula; Mara Z Vitolins; Erica L Rosenberger; David C Goff
Journal:  Contemp Clin Trials       Date:  2010-10-23       Impact factor: 2.226

Review 3.  Red meat, dietary heme iron, and risk of type 2 diabetes: the involvement of advanced lipoxidation endproducts.

Authors:  Desley L White; Avril Collinson
Journal:  Adv Nutr       Date:  2013-07-01       Impact factor: 8.701

Review 4.  Prediabetes and Cardiovascular Disease: Pathophysiology and Interventions for Prevention and Risk Reduction.

Authors:  Ben Brannick; Sam Dagogo-Jack
Journal:  Endocrinol Metab Clin North Am       Date:  2018-03       Impact factor: 4.741

Review 5.  Anti-vascular endothelial growth factor therapy for diabetic macular edema.

Authors:  David S Boyer; J Jill Hopkins; Jonathan Sorof; Jason S Ehrlich
Journal:  Ther Adv Endocrinol Metab       Date:  2013-12       Impact factor: 3.565

Review 6.  A review of rodent models of type 2 diabetic skeletal fragility.

Authors:  Roberto J Fajardo; Lamya Karim; Virginia I Calley; Mary L Bouxsein
Journal:  J Bone Miner Res       Date:  2014       Impact factor: 6.741

7.  Testing whether patients with diabetes and healthy people perceive the meaning of the items in the Persian version of the SF-36 questionnaire similarly: a differential item functioning analysis.

Authors:  Zahra Bagheri; Peyman Jafari; Marzieh Mahmoodi; Mohammad Hossein Dabbaghmanesh
Journal:  Qual Life Res       Date:  2016-10-03       Impact factor: 4.147

8.  Complications in Advanced Diabetics in a Tertiary Care Centre: A Retrospective Registry-Based Study.

Authors:  Amit Dias; Edwin Gomes; Ankush Dessai
Journal:  J Clin Diagn Res       Date:  2016-04-01

9.  Type 2 Diabetes Genetics: Beyond GWAS.

Authors:  Dharambir K Sanghera; Piers R Blackett
Journal:  J Diabetes Metab       Date:  2012-06-23

Review 10.  What is the ideal blood pressure goal for patients with diabetes mellitus and nephropathy?

Authors:  Mark L Lipman; Ernesto L Schiffrin
Journal:  Curr Cardiol Rep       Date:  2012-12       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.